Approval · Notice of Compliance 5232 · 1995
RIFATER: Notice of Compliance 5232
Issued January 12, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5232
- Date
- January 12, 1995
- Company
- Marion Merrell Dow (Canada) Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antituberculous, antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIFATER | 02148625 | Cancelled Post Market |
Medicinal ingredients
- RIFAMPIN 120 MG per TAB
- ISONIAZID 50 MG per TAB
- PYRAZINAMIDE 300 MG per TAB